Do you want to read an article? Please log in or register.
30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes
Retinal Diseases
Related content
RECOMMENDED
Retinal Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ
doi: 10.1016/j.ajo.2026.04.021
Retinal Diseases
Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
Br J Ophthalmol
Guan Z, Li Y, Li Y, Qian Z, Du Y, Yin S, Chen B, Wang H, Jiang J, Chen H, Congdon N, Qiu K
doi: 10.1136/bjo-2025-328581
Macular Diseases
Assessment of real-life visual outcomes and treatment efficacy of diabetic macular edema in patients with type 2 diabetes
BMC Ophthalmol
Konttinen A, Wirkkala J, Kubin AM, Ohtonen P, Hautala N
doi: 10.1186/s12886-026-05083-2
COMMENTED
Retinal Diseases
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Anson M, Iqbal A, Azmi S, Weston P, Hughes L, Choudhury M, Hughes DM, Zheng Y, Burgess PI, Alam U
doi: 10.1111/dom.71084
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007
Further Publications
Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate: A Randomized Clinical Trial
JAMA Ophthalmol
Price FW Jr, Szczotka-Flynn LB, Price MO, Bauza CE, Reed ZW, Arafah BM, Greiner MA, Johnson PJ, Keeler DB, Mian SI, Patel SV, Pramanik S, Soper MC, Terry MA, Titus MS, Verdier DD, Kollman C, Beck RW, Lass JH, Diabetes Endothelial Keratoplasty Study Group
doi: 10.1001/jamaophthalmol.2025.4253
Retinal Diseases
Trends in the Management of Proliferative Diabetic Retinopathy in the First Year After Diagnosis
Retina
Zhang C, Bhatnagar A, Ersan S, Smiddy WE, Flynn HW Jr, Williams BK Jr
doi: 10.1097/IAE.0000000000004861
Retinal Diseases
Looking Beyond Glycaemic Control: Real-World 12-Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes
Diabetes Obes Metab
McNally E, Goodman I, Morris R, Maliekkal J, Saeed D, Tan HW, Berry S, Elliott J, Iqbal A
doi: 10.1111/dom.71129
Retinal DiseasesFurther Publications
Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes
JAMA Ophthalmol
Ramanujam S, Channa R, Liu TYA, Brown EA, Parimi N, Kim YC, Bromberger L, Lehmann HP, Abramoff MD, Wolf RM
doi: 10.1001/jamaophthalmol.2026.1341